United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
A complaint was unsealed today in U.S. District Court in Massachusetts against a New York pharmaceutical company for alleged False Claims Act violations arising from the companys marketing the drugs Celexa and Lexapro for unapproved pediatric use and for paying kickbacks to induce physicians to prescribe the drugs.